Inactive Instrument
CEREP Share Price Euronext Paris
Stocks
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 30/04 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 02/25/02 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 8.68Cr 9.92Cr 8Cr 7.4Cr 14Cr 946.63Cr 14Cr 96Cr 38Cr 464.86Cr 37Cr 36Cr 1.61TCr | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 6.57Cr 7.51Cr 6.06Cr 5.61Cr 11Cr 717.11Cr 11Cr 73Cr 28Cr 352.15Cr 28Cr 28Cr 1.22TCr | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +3.19% | +3.55% | +10.22% | 4.94TCr | |
| +1.58% | +1.99% | +401.04% | +609.30% | 4.03TCr | |
| +2.04% | +0.25% | +28.10% | -5.41% | 3.4TCr | |
| +0.27% | +2.05% | +18.80% | +57.78% | 3.36TCr | |
| -2.09% | -0.80% | +3.56% | +33.56% | 2.68TCr | |
| +0.18% | +1.00% | - | - | 1.72TCr | |
| +0.18% | -4.56% | +65.81% | +120.10% | 1.52TCr | |
| -23.76% | -20.98% | +50.92% | +54.72% | 1.4TCr | |
| +2.59% | -0.49% | +15.24% | +20.83% | 1.34TCr | |
| Average | -1.98% | +0.83% | +73.38% | +112.63% | 2.71TCr | |
| Weighted average by Cap. | -0.56% | +0.90% | +88.01% | +135.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.05Cr 4.63Cr 3.73Cr 3.45Cr 6.56Cr 441.77Cr 6.67Cr 45Cr 18Cr 216.94Cr 17Cr 17Cr 751.45Cr | 4.11Cr 4.7Cr 3.79Cr 3.51Cr 6.66Cr 448.44Cr 6.77Cr 45Cr 18Cr 220.21Cr 18Cr 17Cr 762.79Cr |
| Net income | 71.55L 81.78L 65.98L 61.05L 1.16Cr 78Cr 1.18Cr 7.9Cr 3.1Cr 38Cr 3.07Cr 3Cr 132.79Cr | 47.82L 54.67L 44.1L 40.81L 77.45L 52Cr 78.75L 5.28Cr 2.07Cr 26Cr 2.05Cr 2.01Cr 89Cr |
| Net Debt | -1.73Cr -1.97Cr -1.59Cr -1.47Cr -2.79Cr -188.25Cr -2.84Cr -19Cr -7.47Cr -92Cr -7.4Cr -7.24Cr -320.22Cr | -2.1Cr -2.4Cr -1.94Cr -1.79Cr -3.41Cr -229.52Cr -3.46Cr -23Cr -9.11Cr -112.71Cr -9.03Cr -8.83Cr -390.41Cr |
Employees
-
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
